Dusseldorf - Delayed Quote EUR
CStone Pharmaceuticals (PH4.DU)
0.3220
+0.0180
+(5.92%)
At close: April 23 at 7:30:39 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-588,843
-588,843
-610,743
-1,484,024
-508,070
Investing Cash Flow
619,605
619,605
363,393
-826,552
1,180,732
Financing Cash Flow
388,355
388,355
28,467
92,304
1,389,429
End Cash Position
996,671
996,671
558,684
742,724
3,024,548
Capital Expenditure
-65,047
-65,047
-101,821
-149,136
-71,446
Issuance of Capital Stock
341,824
341,824
2,529
16,830
1,360,928
Issuance of Debt
350,000
350,000
113,042
96,215
58,582
Repayment of Debt
-258,567
-258,567
-32,000
-6,706
-1,580
Repurchase of Capital Stock
--
--
--
--
-21,800
Free Cash Flow
-653,890
-653,890
-712,564
-1,633,160
-579,516
12/31/2020 - 6/25/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2VSA.DU Verastem Inc. R
6.35
+6.72%
473A.SG Adaptimmune Therapeutics PLC
0.2260
+2.73%
IMR.SG AC Immune SA
1.3560
+6.27%
3G0.BE Altimmune Inc
4.4110
+4.03%
F6T.SG Fate Therapeutics Inc
1.1970
+1.57%
MDG1.F Medigene AG
0.2190
+30.36%
TBPH Theravance Biopharma, Inc.
9.45
+1.50%
OCS Oculis Holding AG
17.89
+0.62%
VOR Vor Biopharma Inc.
0.7591
+8.13%
SCPH scPharmaceuticals Inc.
2.6000
-0.38%